SCHEMBL1998248

SCHEMBL1998248

N=C(NCc1ccco1)N1CC[C@@H](OC(=O)[C@](O)(c2ccccc2)C2CCCC2)C1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ CHRM3 P20309 8/20 0.44
▸ CHRM2 P08172 6/20 0.44
▸ CHRM1 P11229 5/20 0.43
▸ HRH1 P35367 2/20 0.43
▸ KCNH2 Q12809 2/20 0.43
▸ CHRM4 P08173 1/20 0.43
▸ CHRM5 P08912 1/20 0.43
▸ HTR2B P41595 1/20 0.43
▸ RECQL P46063 1/20 0.42
▸ HTT P42858 1/20 0.40
▸ SLC29A1 Q99808 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1997731 0.95 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL2248997 0.87 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL1996447 0.87 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL1996570 0.86 ALDH1A1 (0.55) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL1996455 0.85 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL9906137 0.85 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL1995633 0.84 ALDH1A1 (0.55) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL1999859 0.84 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL1999845 0.84 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL1993003 0.83 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039489-B2 Guanidine-containing compounds useful as muscarinic receptor antagonists THERAVANCE, INC. (US) 2011-10-18 — — US disclosed
US-7960385-B2 Guanidine-containing compounds useful as muscarinic receptor antagonists THERAVANCE, INC. (US) 2011-06-14 — — US disclosed
Send feedback